COVID-19 continues to pose a serious health threat to cancer patients, survivors, and the public at large. It is our loved ones, friends, and neighbors who continue to be at risk. In response to...

Last week, the FDA approved, and the CDC recommended a COVID-19 booster for immunocompromised cancer patients. This morning, Dr. Karen E. Knudsen, CEO of the American Cancer Society and American...

A new population-based study show that although national lung cancer screening (LCS) rates decreased in some states, overall LCS rates remained low and unchanged, and 19 states experienced...

As COVID-19 variants cause more sickness and death among those who are not vaccinated across the United States, the American Cancer Society is speaking out in support of vaccination mandates to...

A new study finds that the COVID-19 pandemic contributed to significant disruptions in breast, colorectal and cervical cancer screenings among federally qualified health systems (FQHS) spanning 15...